Medicxi is a life sciences venture capital firm operating from London, Jersey, and Geneva, specializing in biotech investments. It co-founded The Foundation Institute to advance scientific innovation into novel drug candidates and biotech companies, underscoring its leadership in translating research into practical biotech solutions. With a strong presence in the life sciences investment community, Medicxi drives innovation in drug development and biotech entrepreneurship.

‌